Back
Knight Therapeutics Vs. Carvana Industry Stock Comparison
Sell
36
GUD.TO
Knight Therapeutics
Last Price:
$5.43
Seasonality Move:
-2.14%
Sell
50
CVNA
Carvana
Last Price:
$200.67
Seasonality Move:
28.27%
Sell
36
Knight Therapeutics (GUD.TO)
is a Sell
Is Knight Therapeutics a Buy, Sell or Hold?
-
The current Knight Therapeutics [GUD.TO] share price is $5.42. The Score for GUD.TO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
GUD.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Carvana (CVNA)
is a Sell
Is Carvana a Buy, Sell or Hold?
-
CVNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GUD.TO Stock Price Chart
What is Knight Therapeutics's stock price today?
-
The Knight Therapeutics share price today is $5.42Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GUD.TO is experiencing slight buying pressure.
CVNA Stock Price Chart
GUD.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 58.72 | Buy |
| Chaikin Money Flow: | 17498 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.2 - 5.36) | Buy |
| Bollinger Bands (100): | (5.28 - 5.84) | Sell |
CVNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -12.98 | Sell |
| Relative Strength Index (14 RSI): | 30.71 | Sell |
| Chaikin Money Flow: | 3180126 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (209.57 - 256.09) | Sell |
| Bollinger Bands (100): | (160.39 - 240.35) | Sell |
GUD.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.32 | Buy |
| 20-day SMA: | 5.27 | Buy |
| 50-day SMA: | 5.34 | Buy |
| 200-day SMA: | 5.63 | Sell |
| 8-day EMA: | 5.33 | Buy |
| 20-day EMA: | 5.3 | Buy |
| 50-day EMA: | 5.37 | Buy |
| 200-day EMA: | 5.5 | Sell |
CVNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 205.32 | Sell |
| 20-day SMA: | 226.69 | Sell |
| 50-day SMA: | 234.88 | Sell |
| 200-day SMA: | 155.02 | Buy |
| 8-day EMA: | 202.4 | Sell |
| 20-day EMA: | 219.46 | Sell |
| 50-day EMA: | 222.11 | Sell |
| 200-day EMA: | 165.27 | Buy |
Knight Therapeutics Earnings Growth & GUD.TO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.16 per share.
Carvana Earnings Growth & CVNA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $1.43 per share.
Knight Therapeutics Technical Analysis
| Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 20 | 23 | 24 | 27 | 30 | 31 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Carvana Technical Analysis
| Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||